Investor Rights
- Right to receive complete and accurate information about any Mutual Fund scheme before investing.
- Right to know all costs, commissions, and fees (including trail commission received from AMCs).
- Right to a documented risk profile assessment before any scheme recommendation.
- Right to receive written unsuitability communication if a product is outside your risk ceiling.
- Right to transparent, timely grievance redressal within 15 working days.
- Right to access, correct, and request deletion of personal data under DPDPA 2023.
- Right to invest in Direct Plans directly with AMCs at a lower expense ratio.
- Right to switch between Regular and Direct Plans subject to AMC rules.
- Right to escalate unresolved complaints to SEBI SCORES and SMART ODR.
- Right to receive periodic portfolio statements and Consolidated Account Statement (CAS).
Investor Obligations
- Provide accurate and complete KYC and personal information.
- Complete risk profiling before investing and update it on life events or at least annually.
- Read Scheme Information Document (SID), Statement of Additional Information (SAI), and Key Information Memorandum (KIM) before investing.
- Inform us of any changes in personal details, bank accounts, or nominees.
- Review portfolio statements and CAS regularly.
- Do not share login credentials, OTPs, or passwords with anyone — including our staff.
- Comply with FATCA / CRS self-certification requirements.
- Report suspicious communications (phishing, impersonation) immediately.
Distributor Obligations
- Act in the investor's best interest per AMFI Code of Conduct.
- Conduct proper risk profiling before any scheme recommendation.
- Disclose all commissions transparently.
- Not guarantee or promise any specific returns.
- Tag every transaction with the valid EUIN E547548.
- Resolve grievances within 15 working days and maintain the complaints register.
- Maintain investor records as per regulatory requirements.
- Comply with all SEBI and AMFI guidelines including the Master Circular for MFDs.